FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

17516411000001109: Rizatriptan 10mg tablets 12 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Jul 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
60556501000001116 Rizatriptan 10mg tablets 12 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
60556601000001117 Rizatriptan 10mg tablets 12 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

4 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rizatriptan 10mg tablets 12 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets 12 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets 12 tablet Has VMP Product containing precisely rizatriptan (as rizatriptan benzoate) 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets 12 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets 12 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets 12 tablet Has specific active ingredient Rizatriptan benzoate true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets 12 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets 12 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Rizatriptan true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets 12 tablet Has basis of strength substance Rizatriptan true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Maxalt 10mg tablets (Mawdsley-Brooks & Company Ltd) 12 tablet Is a True Rizatriptan 10mg tablets 12 tablet Inferred relationship Existential restriction modifier
Maxalt 10mg tablets (Sigma Pharmaceuticals Plc) 12 tablet Is a True Rizatriptan 10mg tablets 12 tablet Inferred relationship Existential restriction modifier
Maxalt 10mg tablets (Doncaster Pharmaceuticals Ltd) 12 tablet Is a True Rizatriptan 10mg tablets 12 tablet Inferred relationship Existential restriction modifier
Maxalt 10mg tablets (Lexon (UK) Ltd) 12 tablet Is a True Rizatriptan 10mg tablets 12 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start